Nanox partners with Qure.ai to integrate AI-based algorithms for medical imaging in the Nanox.CLOUD

Nanox partners with Qure.ai to integrate AI-based algorithms for medical imaging in the Nanox.CLOUD

Press releases may be edited for formatting or style | April 07, 2020 Artificial Intelligence CT X-Ray
NEVE ILAN, Israel--(BUSINESS WIRE)--NANO-X IMAGING LTD, an innovative medical imaging company, announces its collaboration with Qure.ai, a leading healthcare AI startup, to integrate Qure.ai’s diagnostics solution into Nanox’s planned cloud-based software platform, the Nanox.CLOUD. This partnership follows another agreement with CureMetrix that was announced earlier this year.

Nanox is working to expand the range of medical imaging services it intends to provide to improve the accessibility and affordability of early-detection services. The Nanox.CLOUD is designed to provide an end-to-end medical imaging service, including services such as image repository, radiologist matching, online and offline diagnostics review and annotation, connectivity to diagnostic assistive AI systems, billing and reporting.

A head CT scan is usually a diagnostic test patients undergo at an early stage if they have a head injury or symptoms suggesting stroke. Radiologists in ICUs or ERs might not be immediately available to read a scan or might have many scans pending. Prompt detection of head injury is critical to increase patients’ chances for recovery.

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

Qure.ai’s solution detects critical abnormalities, such as bleeds, fractures, mass effect and midline shift, localizes them and quantifies their severity. Qure.ai’s solutions are all CE certified, and its head CT product (qER) is the only solution in the industry to detect every critical brain abnormality on a head CT, including five types of intracranial hemorrhages, cranial fractures, infarcts, midline shift and mass effect (for tumor detection).

"We’re gradually onboarding the key players in AI and healthcare that share our vision. Qure.ai is joining our planned imaging platform aimed to decrease diagnostic results turnaround time, increase diagnostic accuracy and help radiologists deal with the rising screening demands and workload,” said Ran Poliakine, Founder and CEO of Nanox.

“Our latest partnership with Nanox has the potential to take Qure.ai’s AI-powered diagnostics to a large network of radiologists and clinicians who can benefit from our faster and accurate CT scan interpretation. Our solution that seamlessly integrates with radiologists’ workflow can transform patient care by allowing radiologists to focus on the more critical and urgent patient cases,” explained Prashant Warier, CEO and Co-founder of Qure.ai.


About Nanox:
Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications. Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all.


About Qure.ai:
Headquartered in Mumbai, India, with U.S. operations based in New York, Qure.ai is a breakthrough Artificial Intelligence (AI) solution that is disrupting the radiology ‘status quo’ by enhancing imaging accuracy and improving health outcomes with the assistance of machine-supported tools. Qure.ai taps deep learning technology to provide automated interpretation of radiology exams like X-rays, CTs and MRI scans for time and resource-strapped medical imaging professionals—enabling faster diagnosis and speed to treatment. Qure.ai is helping to make healthcare more accessible and affordable to patients worldwide.

You Must Be Logged In To Post A Comment